Mehrzad, V., Roayaei, M., Peikar, M. S., Nouranian, E., Mokarian, F., Khani, M., & Farzannia, S. (2016). Bevacizumab plus FOLFOX or FOLFIRI regimens on patients with unresectable liver-only metastases of metastatic colorectal cancer. Adv Biomed Res.
Citação norma ChicagoMehrzad, Valiollah, Mahnaz Roayaei, Mohammad Saleh Peikar, Elham Nouranian, Fariborz Mokarian, Mohsen Khani, and Somaieh Farzannia. "Bevacizumab Plus FOLFOX or FOLFIRI Regimens On Patients With Unresectable Liver-only Metastases of Metastatic Colorectal Cancer." Adv Biomed Res 2016.
Citação norma MLAMehrzad, Valiollah, et al. "Bevacizumab Plus FOLFOX or FOLFIRI Regimens On Patients With Unresectable Liver-only Metastases of Metastatic Colorectal Cancer." Adv Biomed Res 2016.